[go: up one dir, main page]

AR015537A1 - Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. - Google Patents

Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.

Info

Publication number
AR015537A1
AR015537A1 ARP990100980A ARP990100980A AR015537A1 AR 015537 A1 AR015537 A1 AR 015537A1 AR P990100980 A ARP990100980 A AR P990100980A AR P990100980 A ARP990100980 A AR P990100980A AR 015537 A1 AR015537 A1 AR 015537A1
Authority
AR
Argentina
Prior art keywords
brinzolamide
manufacture
treat
medicinal product
retina edema
Prior art date
Application number
ARP990100980A
Other languages
English (en)
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of AR015537A1 publication Critical patent/AR015537A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El uso de brinzolamida para la fabricacion de un medicamento para tratar o prevenir el edema de retina que comprende una cantidad farmacéuticamenteefectiva de brinzolamida.
ARP990100980A 1998-03-09 1999-03-08 Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. AR015537A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/036,960 US5948801A (en) 1998-03-09 1998-03-09 Treatment of retinal edema with brinzolamide

Publications (1)

Publication Number Publication Date
AR015537A1 true AR015537A1 (es) 2001-05-02

Family

ID=21891660

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100980A AR015537A1 (es) 1998-03-09 1999-03-08 Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.

Country Status (5)

Country Link
US (1) US5948801A (es)
AR (1) AR015537A1 (es)
AU (1) AU2573099A (es)
WO (1) WO1999045929A1 (es)
ZA (1) ZA991224B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073708A1 (en) * 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
ATE375141T1 (de) * 2000-03-10 2007-10-15 Insite Vision Inc Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
AU2001280093A1 (en) * 2000-08-11 2002-02-25 Einar Stefansson Method for the prevention and treatment of retinopathy
US20110021974A1 (en) * 2010-10-05 2011-01-27 Shantha Totada R Retinitis pigmentosa treatment and prophalaxis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
EP0954305B9 (en) * 1996-02-26 2010-08-04 Advanced Research & Technology Institute Use of carbonic anhydrase inhibitors for treating macular edema
EP1024810A4 (en) * 1997-06-26 2003-06-11 Merck & Co Inc METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE

Also Published As

Publication number Publication date
WO1999045929A1 (en) 1999-09-16
ZA991224B (en) 1999-10-08
US5948801A (en) 1999-09-07
AU2573099A (en) 1999-09-27

Similar Documents

Publication Publication Date Title
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ES2163504T3 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
AR028959A1 (es) Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
NO20032027D0 (no) Effektive antitumorbehandlinger
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
AR037524A1 (es) Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
IL156798A0 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependency
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
PT1150704E (pt) Melagatran para o tratamento da inflamacao
AR015537A1 (es) Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
ES2185310T3 (es) Agente antivirico herbario.
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.

Legal Events

Date Code Title Description
FB Suspension of granting procedure